Insider Transactions in Q1 2022 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
18
-0.0%
|
$342
$19.0 P/Share
|
|
Mar 14
2022
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
7,359,304
+49.66%
|
-
|
|
Jan 19
2022
|
Terrie Curran President and Chief Executive |
BUY
Grant, award, or other acquisition
|
Direct |
41,250
+48.33%
|
-
|
|
Jan 19
2022
|
Anthony J. Guzzo VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+41.67%
|
-
|
|
Jan 19
2022
|
Azmi Nabulsi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+47.7%
|
-
|